What Ocugen, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 4 | 4 |
| Total trades | 4 | 10 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 3,545,635 |
| Disposed | 1,051,982 | 1,051,982 |
| Net activity | −1,051,982 | +2,493,653 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Musunuri Shankar | Chief Executive Officer | Oct 09 | Disclosed 10b5-1 sale · S | −57,264 | $0.95 | −$54.4K | 1,030,771 |
| Musunuri Shankar | Chief Executive Officer | Oct 09 | Disclosed 10b5-1 sale · S | −468,727 | $0.95 | −$445K | 4,018,470 |
| Musunuri Shankar | Chief Executive Officer | Sep 09 | Disclosed 10b5-1 sale · S | −57,264 | $1.12 | −$64.1K | 1,088,035 |
| Musunuri Shankar | Chief Executive Officer | Sep 09 | Disclosed 10b5-1 sale · S | −468,727 | $1.12 | −$525K | 4,487,197 |
| Johnson-Greene Treerita Essalima | Chief Financial Officer | Jun 15 | Open-market buy · P | +21,000 | $1.23 | +$25.8K | 521,000 |
| Zhang Junge | Director | Apr 01 | Exercise / conversion · M | +66,929 | $1.42 | +$95K | 1,359,316 |
| Zhang Junge | Director | Apr 01 | Exercise / conversion · M | +112,205 | $0.46 | +$51.6K | 1,292,387 |
| Zhang Junge | Director | Apr 01 | Exercise / conversion · M | +15,000 | $0.51 | +$7.65K | 1,180,182 |
| Musunuri Shankar | Chief Executive Officer | Jan 02 | Grant / award · A | +3,123,201 | — | — | 4,955,924 |
| Ramachandran Ramesh | Chief Accounting Officer | Jan 02 | Grant / award · A | +207,300 | — | — | 209,100 |
| Upadhyay Arun | See Remarks | Jan 03 | Withheld — tax / exercise cost · F | −41,633 | $0.89 | −$37.2K | 306,197 |
| Musunuri Shankar | Chief Executive Officer | Jan 03 | Withheld — tax / exercise cost · F | −177,146 | $0.89 | −$158K | 1,832,723 |
| Fernandes Prabhavathi | Director | Nov 26 | Open-market buy · P | +10,000 | $0.91 | +$9.1K | 10,000 |
| Castillo Kirsten | Director | Nov 22 | Open-market buy · P | +25,000 | $0.91 | +$22.8K | 75,000 |
| Upadhyay Arun | See Remarks | Sep 16 | Withheld — tax / exercise cost · F | −842 | $1.17 | −$985 | 347,830 |
| Upadhyay Arun | See Remarks | Jun 17 | Withheld — tax / exercise cost · F | −917 | $1.42 | −$1.3K | 348,672 |
| Musunuri Shankar | Chief Executive Officer | Jan 03 | Withheld — tax / exercise cost · F | −180,204 | $0.65 | −$118K | 2,009,869 |
| Upadhyay Arun | See Remarks | Jan 03 | Withheld — tax / exercise cost · F | −41,633 | $0.65 | −$27.2K | 349,589 |
| Upadhyay Arun | See Remarks | Sep 16 | Withheld — tax / exercise cost · F | −842 | $0.41 | −$345 | 391,222 |
| Upadhyay Arun | Chief Scientific Officer | Jun 16 | Withheld — tax / exercise cost · F | −917 | $0.51 | −$468 | 392,064 |
Loading...